The SURMOUNT trial program provides extensive data on what tirzepatide achieves without any additional weight loss medication: 5 mg dose: 15.0% average weight loss at 72 weeks 10 mg dose: 19.5% average weight loss at 72 weeks 15 mg dose: 20.9% average weight loss at 72 weeks At 15 mg, 56.1% of participants lost at least 20% of body weight At 15 mg, 38.7% of participants lost at least 25% of body weight These numbers are remarkable
At Cymbiotika, we take that trust seriously
By Jordan Stern, MD About the author: Jordan Stern, MD, Founder and CEO of BlueSleep, is a Head and Neck surgeon, a subspecialty of Ear, Nose and Throat (ENT or Otolaryngology), who has treated over 10,000 sleep apnea patients and published multiple studies on the diagnosis and treatment of Sleep Apnea
Nasal sprays still carry the unregulated product problem
Liraglutide treatment reduced synovial inflammation in rheumatoid arthritis models 41
When it comes to costs, lipotropic injections can be a more affordable option than semaglutide injections if youre paying out of pocket